Financials in USD. Standardized financial statements.
A compact view of how Core Laboratories N.V. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $526.52M | $523.85M | $509.79M | $489.74M | $470.25M | $487.27M | $668.21M | $700.85M | $659.81M | $594.74M |
| Revenue Growth? | +0.5% | +2.8% | +4.1% | +4.1% | -3.5% | -27.1% | -4.7% | +6.2% | +10.9% | 0.0% |
| Cost of Revenue? | $432.24M | $435.48M | $415.74M | $410.82M | $386.41M | $385.14M | $495.58M | $520.05M | $499.18M | $469.52M |
| Gross Profit? | $94.28M | $88.37M | $94.05M | $78.92M | $83.84M | $102.13M | $172.63M | $180.79M | $160.63M | $125.22M |
| Gross Margin? | +17.9% | +16.9% | +18.4% | +16.1% | +17.8% | +21.0% | +25.8% | +25.8% | +24.3% | +21.1% |
| Operating Expenses? | $43.80M | $29.82M | $39.41M | $37.40M | $38.58M | $178.93M | $75.95M | $62.91M | $47.74M | $39.39M |
| Operating Income? | $50.49M | $58.56M | $54.64M | $41.52M | $45.26M | -$76.81M | $96.68M | $118.62M | $112.44M | $86.18M |
| EBITDA? | $71.12M | $73.27M | $70.42M | $58.69M | $63.78M | $70.49M | $124.62M | $141.71M | $134.49M | $114.32M |
| Income Before Tax | $45.90M | $46.19M | $41.21M | $29.95M | $36.11M | -$91.18M | $81.99M | $105.29M | $101.71M | $74.61M |
| Income Tax Expense | $15.51M | $14.03M | $4.18M | $10.30M | $15.89M | $5.90M | -$12.29M | $25.45M | $18.61M | $10.75M |
| Net Income? | $29.67M | $31.40M | $36.67M | $19.45M | $19.73M | -$97.64M | $101.98M | $79.53M | $83.13M | $63.90M |
| EPS? | $0.68 | $0.67 | $0.79 | $0.42 | $0.43 | $-2.18 | $2.11 | $1.80 | $1.88 | $1.45 |
| Diluted EPS? | $0.68 | $0.66 | $0.77 | $0.42 | $0.42 | $-2.16 | $2.10 | $1.79 | $1.88 | $1.45 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality